Farmaceutica REMEDIA S A : Decision no. 80 of 27.01.2022 E.G.M.S.

DECISION NO. 80 of January 27th 2022

of the Extraordinary General Meeting of Shareholders

Farmaceutica REMEDIA S.A.

J20/700/1991, CUI RO 2115198

Deva, N. Balcescu Blvd, no. 2, Hunedoara County

Adopted today, 27.01.2022 at the secondary headquarters of the company from BUCHAREST, B-dul Metalurgiei no. 78, sector 4.

Following the debate of the items on the agenda, the Extraordinary General Meeting of Shareholders decides, with the vote of the shareholders present and represented holding a number of 80.497.990 voting shares, representing 84,3080% of the total number of voting shares in the share capital of Farmaceutica REMEDIA SA (total voting shares 95.480.820 representing 100% of the share capital of Farmaceutica REMEDIA S.A.), the following:

Art. 1. With a total of 80.497.990 votes expressed, representing 84,3080% of the share capital, of which 80.497.990 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:

Approval of the acquisition of a 50% participation in the share capital of the Romanian legal entity PHARMA EXPERTSPEDITION S.R.L. with headquarter in Bucharest, Bd. Metalurgiei, no. 130E, Sector 4, registered at the Bucharest Trade Register under no. J40/20206/2005, with CUI 18178346, in order to develop and consolidate the distribution and logistics activity, at the price of 600.000 lei.

Art. 2. With a total of 80.497.990 votes expressed, representing 84,3080% of the share capital, of which 80.497.990 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:

The empowerment of Mr. Valentin - Norbert TARUS, in his position as Director General, to sign all the documents necessary for the implementation of this Decision.

Art. 3. With a total of 80.497.990 votes expressed, representing 84,3080% of the share capital, of which 80.497.990 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:

Approval of the date of 17.02.2022 as the registration date, in compliance with the provisions of Art. 87 (1) of Law No. 24/2017.

Art. 4. With a total of 80.497.990 votes expressed, representing 84,3080% of the share capital, of which 80.497.990 votes FOR, no votes AGAINST and no ABSTENTIONS, all votes being valid, the AGM decides:

Approval of the date of 16.02.2022 as ex-date, in compliance with the provisions of Art. 176 (1) from the FSA Regulation No. 5/2018 and Art. 2 (2) letter l from the FSA Regulation No. 5/2018.

The President of the Extraordinary General Meeting of the Shareholders

The Secretary of the Extraordinary General Meeting of the Shareholders